Clinical Performance of Resin Composite Restoration After Dentin Biomodification by Grape Seed Extract in Deep Carious Lesions.
Launched by CAIRO UNIVERSITY · Jan 13, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a dental treatment works for people with deep cavities in their back teeth. The researchers want to see if using a natural substance called grape seed extract can improve the way a special filling material sticks to the tooth after some soft, decayed parts are carefully removed. This study will focus on adults aged 22 to 42 who have certain types of deep cavities, but not everyone will be eligible to participate.
To join the study, participants must have good oral hygiene and be able to follow up after the treatment. They should not have any allergies to the materials used, be pregnant, or have any serious health issues. If you take pain medications regularly or have certain dental problems like previous fillings or severe pain, you might not be able to participate. Those who do join can expect to receive a filling and will have their tooth's health monitored over time to see how well the treatment works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient-related criteria:
- • 1. Adult patients (age: 22-42 years) of both genders.
- • 2. Good oral hygiene.
- • 3. Willing to sign the informed consent.
- • 4. Co-operative patients who accept the follow-up period.
- * Tooth-related criteria:
- • 1. Posterior permanent caries (ICDAS 5\&6).
- • 2. Radiographically, caries is extending 50% of dentine with a radiopaque layer between the carious lesion and the pulp chamber.
- • 3. Sensible teeth according to cold pulp test.
- • 4. Negative response in percussion test.
- Exclusion Criteria:
- * Patient-related criteria:
- • 1. Allergy to any of the restorative materials.
- • 2. Patients undergoing orthodontic treatment with fixed appliances.
- • 3. Pregnant women.
- • 4. Patients with debilitating systemic diseases.
- • 5. Patient who frequently use analgesic or any drugs that could mask the pain.
- * Tooth-related criteria:
- • 1. Teeth with previous restorations.
- • 2. Spontaneous pain or prolonged pain (more than 15 s) after sensitivity test (cold test), which would indicate irreversible pulpitis.
- • 3. Negative sensibility tests, periapical radiolucencies and sensitivity to axial or lateral percussion.
- • 4. Mobile teeth, indicating periodontal disease or trauma.
- • 5. External or internal resorption.
- • 6. Chipped teeth or Cuspal loss
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Pro. Heba Salah El Din Hamza (H.H.) Head of Conservative Dentistry Department, Cairo University., Professor
Study Director
Professor, Conservative Dentistry Department, Faculty of Dentistry, Cairo University, Egypt.
Dr. Rawda Hesham Abd ElAziz (R.H.) Lecturer of Conservative Dentistry Department,Cairo University, Lecturer
Study Director
Lecturer of Conservative Dentistry Department, Faculty of Dentistry, Cairo University, Egypt.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported